TMC Life Sciences Berhad

KLSE:TMCLIFE Stock Report

Market Cap: RM1.2b

TMC Life Sciences Berhad Past Earnings Performance

Past criteria checks 5/6

TMC Life Sciences Berhad has been growing earnings at an average annual rate of 19.7%, while the Healthcare industry saw earnings growing at 22% annually. Revenues have been growing at an average rate of 13.1% per year. TMC Life Sciences Berhad's return on equity is 6.5%, and it has net margins of 16.2%.

Key information

19.7%

Earnings growth rate

19.6%

EPS growth rate

Healthcare Industry Growth31.5%
Revenue growth rate13.1%
Return on equity6.5%
Net Margin16.2%
Last Earnings Update31 Dec 2023

Recent past performance updates

Recent updates

TMC Life Sciences Berhad (KLSE:TMCLIFE) Seems To Use Debt Quite Sensibly

Feb 14
TMC Life Sciences Berhad (KLSE:TMCLIFE) Seems To Use Debt Quite Sensibly

We Think TMC Life Sciences Berhad (KLSE:TMCLIFE) Can Stay On Top Of Its Debt

Sep 29
We Think TMC Life Sciences Berhad (KLSE:TMCLIFE) Can Stay On Top Of Its Debt

Investors Met With Slowing Returns on Capital At TMC Life Sciences Berhad (KLSE:TMCLIFE)

Aug 26
Investors Met With Slowing Returns on Capital At TMC Life Sciences Berhad (KLSE:TMCLIFE)

TMC Life Sciences Berhad (KLSE:TMCLIFE) Shareholders Will Want The ROCE Trajectory To Continue

May 26
TMC Life Sciences Berhad (KLSE:TMCLIFE) Shareholders Will Want The ROCE Trajectory To Continue

TMC Life Sciences Berhad's (KLSE:TMCLIFE) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?

Feb 09
TMC Life Sciences Berhad's (KLSE:TMCLIFE) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?

Returns On Capital - An Important Metric For TMC Life Sciences Berhad (KLSE:TMCLIFE)

Jan 13
Returns On Capital - An Important Metric For TMC Life Sciences Berhad (KLSE:TMCLIFE)

Would Shareholders Who Purchased TMC Life Sciences Berhad's (KLSE:TMCLIFE) Stock Three Years Be Happy With The Share price Today?

Dec 22
Would Shareholders Who Purchased TMC Life Sciences Berhad's (KLSE:TMCLIFE) Stock Three Years Be Happy With The Share price Today?

Should You Use TMC Life Sciences Berhad's (KLSE:TMCLIFE) Statutory Earnings To Analyse It?

Dec 02
Should You Use TMC Life Sciences Berhad's (KLSE:TMCLIFE) Statutory Earnings To Analyse It?

Revenue & Expenses Breakdown
Beta

How TMC Life Sciences Berhad makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

KLSE:TMCLIFE Revenue, expenses and earnings (MYR Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Dec 233535700
30 Sep 233324800
30 Jun 233123900
31 Mar 232984900
31 Dec 222774200
30 Sep 222634400
30 Jun 222444100
31 Mar 222262200
31 Dec 212131800
30 Sep 212031700
30 Jun 212012000
30 Jun 201841600
31 May 201901000
29 Feb 202062200
30 Nov 192002200
31 Aug 191952100
31 May 1918733880
28 Feb 1918030880
30 Nov 1817429880
31 Aug 181692800
31 May 1816528280
28 Feb 1816128460
30 Nov 1715728620
31 Aug 1715226790
31 May 1714621790
28 Feb 1714020770
30 Nov 1613619760
31 Aug 1613118740
29 Feb 1612113690
30 Nov 1511613670
31 Aug 1510710550
31 May 1510310610
28 Feb 15989570
30 Nov 14947540
31 Aug 14918520
31 May 14866510
28 Feb 14825500
30 Nov 13783480
31 Aug 13732460
31 May 13712440

Quality Earnings: TMCLIFE has high quality earnings.

Growing Profit Margin: TMCLIFE's current net profit margins (16.2%) are higher than last year (15.2%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: TMCLIFE's earnings have grown by 19.7% per year over the past 5 years.

Accelerating Growth: TMCLIFE's earnings growth over the past year (35.7%) exceeds its 5-year average (19.7% per year).

Earnings vs Industry: TMCLIFE earnings growth over the past year (35.7%) exceeded the Healthcare industry 12.8%.


Return on Equity

High ROE: TMCLIFE's Return on Equity (6.5%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.